LBP-041 HSK31679, a thyroid hormone receptor beta agonist, improves histological outcomes in Asian patients with MASH and F2–F3 fibrosis: a 52-week phase 2b randomized, double-blind, placebo-controlled trial
Year: 2026
Type: conference-abstract
Source: Journal of Hepatology
Authors: Feng Xue, Jianfeng Liu, Jinjun Chen, Xing Li, Sikui Wang, Yawen Luo, Bangjie Zhang, Jiawei Geng, Weihong Wang, Rui Zhao, Chuanwu Zhu, Junjun Bi, Xiqing Guo, Lungen Lu, Guang-Ming Li, Hong Peng, Li Dong, Guohong Ge, Danying Cheng, Xianfei Zhong, Lvfeng Yao, Feng Gao, Shiyao Chen, Jiaojian Lv, Liang Xu, Guodong Zhang, Xiao zhong Wang, Gang He, Yaocai Li, Xiuping Jin, Wang Jing, Huiying Rao, Shuilin Sun, Yunzhen Shi, Min Meng, Jing Zhang, Muyessar Maimaitiyiming, Chao Wu, Cunliang Deng, Zong Zhang, Yan Bi, Xiaohua Li, Tingting Wu, Weifang Zeng, Lai Wei
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162503585
